nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—breast cancer—ovarian cancer	0.709	1	CtDrD
Letrozole—CYP19A1—Paclitaxel—ovarian cancer	0.0783	0.58	CbGbCtD
Letrozole—CYP19A1—follicular fluid—ovarian cancer	0.0203	0.428	CbGeAlD
Letrozole—CYP3A4—Topotecan—ovarian cancer	0.02	0.149	CbGbCtD
Letrozole—CYP3A4—Vinorelbine—ovarian cancer	0.0141	0.105	CbGbCtD
Letrozole—CYP19A1—corpus luteum—ovarian cancer	0.0117	0.247	CbGeAlD
Letrozole—CYP3A4—Paclitaxel—ovarian cancer	0.00991	0.0735	CbGbCtD
Letrozole—CYP19A1—ovarian follicle—ovarian cancer	0.00913	0.193	CbGeAlD
Letrozole—CYP3A4—Docetaxel—ovarian cancer	0.00717	0.0532	CbGbCtD
Letrozole—CYP3A4—Doxorubicin—ovarian cancer	0.00534	0.0396	CbGbCtD
Letrozole—CYP19A1—endometrium—ovarian cancer	0.000903	0.0191	CbGeAlD
Letrozole—CYP2A6—vagina—ovarian cancer	0.000863	0.0182	CbGeAlD
Letrozole—CYP19A1—gonad—ovarian cancer	0.000838	0.0177	CbGeAlD
Letrozole—CYP19A1—uterus—ovarian cancer	0.000832	0.0176	CbGeAlD
Letrozole—CYP19A1—female reproductive system—ovarian cancer	0.000748	0.0158	CbGeAlD
Letrozole—CYP19A1—female gonad—ovarian cancer	0.000681	0.0144	CbGeAlD
Letrozole—CYP19A1—testis—ovarian cancer	0.000604	0.0128	CbGeAlD
Letrozole—CYP19A1—lymph node—ovarian cancer	0.000438	0.00925	CbGeAlD
Letrozole—CYP3A4—female reproductive system—ovarian cancer	0.000363	0.00767	CbGeAlD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	8.76e-05	0.000803	CcSEcCtD
Letrozole—Nausea—Topotecan—ovarian cancer	8.72e-05	0.0008	CcSEcCtD
Letrozole—Discomfort—Paclitaxel—ovarian cancer	8.71e-05	0.000799	CcSEcCtD
Letrozole—Dry mouth—Paclitaxel—ovarian cancer	8.62e-05	0.00079	CcSEcCtD
Letrozole—Diarrhoea—Vinorelbine—ovarian cancer	8.6e-05	0.000788	CcSEcCtD
Letrozole—Dysgeusia—Docetaxel—ovarian cancer	8.6e-05	0.000788	CcSEcCtD
Letrozole—Nausea—Melphalan—ovarian cancer	8.54e-05	0.000783	CcSEcCtD
Letrozole—Influenza—Epirubicin—ovarian cancer	8.5e-05	0.000779	CcSEcCtD
Letrozole—Back pain—Docetaxel—ovarian cancer	8.49e-05	0.000778	CcSEcCtD
Letrozole—Oedema—Paclitaxel—ovarian cancer	8.45e-05	0.000775	CcSEcCtD
Letrozole—Anaphylactic shock—Paclitaxel—ovarian cancer	8.45e-05	0.000775	CcSEcCtD
Letrozole—Infection—Paclitaxel—ovarian cancer	8.4e-05	0.00077	CcSEcCtD
Letrozole—Dry skin—Doxorubicin—ovarian cancer	8.34e-05	0.000764	CcSEcCtD
Letrozole—Dizziness—Vinorelbine—ovarian cancer	8.31e-05	0.000762	CcSEcCtD
Letrozole—Nervous system disorder—Paclitaxel—ovarian cancer	8.29e-05	0.00076	CcSEcCtD
Letrozole—Angina pectoris—Epirubicin—ovarian cancer	8.28e-05	0.000759	CcSEcCtD
Letrozole—Tachycardia—Paclitaxel—ovarian cancer	8.25e-05	0.000756	CcSEcCtD
Letrozole—Breast disorder—Doxorubicin—ovarian cancer	8.22e-05	0.000754	CcSEcCtD
Letrozole—Skin disorder—Paclitaxel—ovarian cancer	8.21e-05	0.000753	CcSEcCtD
Letrozole—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	8.19e-05	0.000751	CcSEcCtD
Letrozole—Hyperhidrosis—Paclitaxel—ovarian cancer	8.17e-05	0.000749	CcSEcCtD
Letrozole—Anorexia—Paclitaxel—ovarian cancer	8.06e-05	0.000739	CcSEcCtD
Letrozole—Vomiting—Vinorelbine—ovarian cancer	7.99e-05	0.000732	CcSEcCtD
Letrozole—Rash—Vinorelbine—ovarian cancer	7.92e-05	0.000726	CcSEcCtD
Letrozole—Dermatitis—Vinorelbine—ovarian cancer	7.91e-05	0.000726	CcSEcCtD
Letrozole—Headache—Vinorelbine—ovarian cancer	7.87e-05	0.000722	CcSEcCtD
Letrozole—Influenza—Doxorubicin—ovarian cancer	7.86e-05	0.000721	CcSEcCtD
Letrozole—Leukopenia—Docetaxel—ovarian cancer	7.86e-05	0.00072	CcSEcCtD
Letrozole—Pollakiuria—Epirubicin—ovarian cancer	7.85e-05	0.00072	CcSEcCtD
Letrozole—Palpitations—Docetaxel—ovarian cancer	7.76e-05	0.000711	CcSEcCtD
Letrozole—Weight increased—Epirubicin—ovarian cancer	7.73e-05	0.000709	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	7.7e-05	0.000706	CcSEcCtD
Letrozole—Weight decreased—Epirubicin—ovarian cancer	7.69e-05	0.000705	CcSEcCtD
Letrozole—Cough—Docetaxel—ovarian cancer	7.66e-05	0.000702	CcSEcCtD
Letrozole—Angina pectoris—Doxorubicin—ovarian cancer	7.66e-05	0.000702	CcSEcCtD
Letrozole—Insomnia—Paclitaxel—ovarian cancer	7.64e-05	0.000701	CcSEcCtD
Letrozole—Paraesthesia—Paclitaxel—ovarian cancer	7.59e-05	0.000696	CcSEcCtD
Letrozole—Hypertension—Docetaxel—ovarian cancer	7.58e-05	0.000695	CcSEcCtD
Letrozole—Infestation—Epirubicin—ovarian cancer	7.58e-05	0.000695	CcSEcCtD
Letrozole—Infestation NOS—Epirubicin—ovarian cancer	7.58e-05	0.000695	CcSEcCtD
Letrozole—Dyspnoea—Paclitaxel—ovarian cancer	7.53e-05	0.000691	CcSEcCtD
Letrozole—Somnolence—Paclitaxel—ovarian cancer	7.51e-05	0.000689	CcSEcCtD
Letrozole—Arthralgia—Docetaxel—ovarian cancer	7.47e-05	0.000685	CcSEcCtD
Letrozole—Chest pain—Docetaxel—ovarian cancer	7.47e-05	0.000685	CcSEcCtD
Letrozole—Myalgia—Docetaxel—ovarian cancer	7.47e-05	0.000685	CcSEcCtD
Letrozole—Nausea—Vinorelbine—ovarian cancer	7.46e-05	0.000684	CcSEcCtD
Letrozole—Dyspepsia—Paclitaxel—ovarian cancer	7.44e-05	0.000682	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	7.42e-05	0.00068	CcSEcCtD
Letrozole—Stomatitis—Epirubicin—ovarian cancer	7.38e-05	0.000677	CcSEcCtD
Letrozole—Urinary tract infection—Epirubicin—ovarian cancer	7.36e-05	0.000675	CcSEcCtD
Letrozole—Decreased appetite—Paclitaxel—ovarian cancer	7.35e-05	0.000674	CcSEcCtD
Letrozole—Dry mouth—Docetaxel—ovarian cancer	7.31e-05	0.00067	CcSEcCtD
Letrozole—Gastrointestinal disorder—Paclitaxel—ovarian cancer	7.3e-05	0.000669	CcSEcCtD
Letrozole—Fatigue—Paclitaxel—ovarian cancer	7.29e-05	0.000668	CcSEcCtD
Letrozole—Sweating—Epirubicin—ovarian cancer	7.26e-05	0.000666	CcSEcCtD
Letrozole—Pollakiuria—Doxorubicin—ovarian cancer	7.26e-05	0.000666	CcSEcCtD
Letrozole—Constipation—Paclitaxel—ovarian cancer	7.23e-05	0.000663	CcSEcCtD
Letrozole—Pain—Paclitaxel—ovarian cancer	7.23e-05	0.000663	CcSEcCtD
Letrozole—Hepatobiliary disease—Epirubicin—ovarian cancer	7.16e-05	0.000657	CcSEcCtD
Letrozole—Oedema—Docetaxel—ovarian cancer	7.16e-05	0.000657	CcSEcCtD
Letrozole—Anaphylactic shock—Docetaxel—ovarian cancer	7.16e-05	0.000657	CcSEcCtD
Letrozole—Weight increased—Doxorubicin—ovarian cancer	7.15e-05	0.000656	CcSEcCtD
Letrozole—Infection—Docetaxel—ovarian cancer	7.12e-05	0.000652	CcSEcCtD
Letrozole—Weight decreased—Doxorubicin—ovarian cancer	7.11e-05	0.000652	CcSEcCtD
Letrozole—Nervous system disorder—Docetaxel—ovarian cancer	7.02e-05	0.000644	CcSEcCtD
Letrozole—Infestation NOS—Doxorubicin—ovarian cancer	7.01e-05	0.000643	CcSEcCtD
Letrozole—Infestation—Doxorubicin—ovarian cancer	7.01e-05	0.000643	CcSEcCtD
Letrozole—Tachycardia—Docetaxel—ovarian cancer	6.99e-05	0.000641	CcSEcCtD
Letrozole—Feeling abnormal—Paclitaxel—ovarian cancer	6.96e-05	0.000638	CcSEcCtD
Letrozole—Skin disorder—Docetaxel—ovarian cancer	6.96e-05	0.000638	CcSEcCtD
Letrozole—Gastrointestinal pain—Paclitaxel—ovarian cancer	6.91e-05	0.000634	CcSEcCtD
Letrozole—Haemoglobin—Epirubicin—ovarian cancer	6.84e-05	0.000627	CcSEcCtD
Letrozole—Stomatitis—Doxorubicin—ovarian cancer	6.83e-05	0.000626	CcSEcCtD
Letrozole—Anorexia—Docetaxel—ovarian cancer	6.83e-05	0.000626	CcSEcCtD
Letrozole—Urinary tract infection—Doxorubicin—ovarian cancer	6.81e-05	0.000625	CcSEcCtD
Letrozole—Haemorrhage—Epirubicin—ovarian cancer	6.8e-05	0.000623	CcSEcCtD
Letrozole—Hepatitis—Epirubicin—ovarian cancer	6.8e-05	0.000623	CcSEcCtD
Letrozole—Hypoaesthesia—Epirubicin—ovarian cancer	6.77e-05	0.00062	CcSEcCtD
Letrozole—Sweating—Doxorubicin—ovarian cancer	6.72e-05	0.000616	CcSEcCtD
Letrozole—Urinary tract disorder—Epirubicin—ovarian cancer	6.72e-05	0.000616	CcSEcCtD
Letrozole—Urticaria—Paclitaxel—ovarian cancer	6.71e-05	0.000616	CcSEcCtD
Letrozole—Oedema peripheral—Epirubicin—ovarian cancer	6.7e-05	0.000614	CcSEcCtD
Letrozole—Connective tissue disorder—Epirubicin—ovarian cancer	6.68e-05	0.000613	CcSEcCtD
Letrozole—Body temperature increased—Paclitaxel—ovarian cancer	6.68e-05	0.000613	CcSEcCtD
Letrozole—Abdominal pain—Paclitaxel—ovarian cancer	6.68e-05	0.000613	CcSEcCtD
Letrozole—Urethral disorder—Epirubicin—ovarian cancer	6.67e-05	0.000611	CcSEcCtD
Letrozole—Hepatobiliary disease—Doxorubicin—ovarian cancer	6.63e-05	0.000608	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Docetaxel—ovarian cancer	6.53e-05	0.000598	CcSEcCtD
Letrozole—Insomnia—Docetaxel—ovarian cancer	6.48e-05	0.000594	CcSEcCtD
Letrozole—Paraesthesia—Docetaxel—ovarian cancer	6.43e-05	0.00059	CcSEcCtD
Letrozole—Erythema multiforme—Epirubicin—ovarian cancer	6.43e-05	0.00059	CcSEcCtD
Letrozole—Dyspnoea—Docetaxel—ovarian cancer	6.39e-05	0.000586	CcSEcCtD
Letrozole—Somnolence—Docetaxel—ovarian cancer	6.37e-05	0.000584	CcSEcCtD
Letrozole—Eye disorder—Epirubicin—ovarian cancer	6.36e-05	0.000583	CcSEcCtD
Letrozole—Haemoglobin—Doxorubicin—ovarian cancer	6.32e-05	0.00058	CcSEcCtD
Letrozole—Flushing—Epirubicin—ovarian cancer	6.31e-05	0.000579	CcSEcCtD
Letrozole—Cardiac disorder—Epirubicin—ovarian cancer	6.31e-05	0.000579	CcSEcCtD
Letrozole—Dyspepsia—Docetaxel—ovarian cancer	6.31e-05	0.000578	CcSEcCtD
Letrozole—Hepatitis—Doxorubicin—ovarian cancer	6.29e-05	0.000577	CcSEcCtD
Letrozole—Haemorrhage—Doxorubicin—ovarian cancer	6.29e-05	0.000577	CcSEcCtD
Letrozole—Hypoaesthesia—Doxorubicin—ovarian cancer	6.26e-05	0.000574	CcSEcCtD
Letrozole—Decreased appetite—Docetaxel—ovarian cancer	6.23e-05	0.000571	CcSEcCtD
Letrozole—Urinary tract disorder—Doxorubicin—ovarian cancer	6.21e-05	0.00057	CcSEcCtD
Letrozole—Oedema peripheral—Doxorubicin—ovarian cancer	6.2e-05	0.000568	CcSEcCtD
Letrozole—Gastrointestinal disorder—Docetaxel—ovarian cancer	6.18e-05	0.000567	CcSEcCtD
Letrozole—Connective tissue disorder—Doxorubicin—ovarian cancer	6.18e-05	0.000567	CcSEcCtD
Letrozole—Fatigue—Docetaxel—ovarian cancer	6.18e-05	0.000566	CcSEcCtD
Letrozole—Angiopathy—Epirubicin—ovarian cancer	6.17e-05	0.000566	CcSEcCtD
Letrozole—Urethral disorder—Doxorubicin—ovarian cancer	6.17e-05	0.000566	CcSEcCtD
Letrozole—Mediastinal disorder—Epirubicin—ovarian cancer	6.13e-05	0.000562	CcSEcCtD
Letrozole—Constipation—Docetaxel—ovarian cancer	6.13e-05	0.000562	CcSEcCtD
Letrozole—Pain—Docetaxel—ovarian cancer	6.13e-05	0.000562	CcSEcCtD
Letrozole—Asthenia—Paclitaxel—ovarian cancer	6.06e-05	0.000556	CcSEcCtD
Letrozole—Alopecia—Epirubicin—ovarian cancer	6.01e-05	0.000551	CcSEcCtD
Letrozole—Pruritus—Paclitaxel—ovarian cancer	5.98e-05	0.000548	CcSEcCtD
Letrozole—Mental disorder—Epirubicin—ovarian cancer	5.96e-05	0.000546	CcSEcCtD
Letrozole—Erythema multiforme—Doxorubicin—ovarian cancer	5.95e-05	0.000545	CcSEcCtD
Letrozole—Malnutrition—Epirubicin—ovarian cancer	5.92e-05	0.000543	CcSEcCtD
Letrozole—Feeling abnormal—Docetaxel—ovarian cancer	5.9e-05	0.000541	CcSEcCtD
Letrozole—Eye disorder—Doxorubicin—ovarian cancer	5.88e-05	0.000539	CcSEcCtD
Letrozole—Gastrointestinal pain—Docetaxel—ovarian cancer	5.86e-05	0.000537	CcSEcCtD
Letrozole—Cardiac disorder—Doxorubicin—ovarian cancer	5.84e-05	0.000535	CcSEcCtD
Letrozole—Flushing—Doxorubicin—ovarian cancer	5.84e-05	0.000535	CcSEcCtD
Letrozole—Tension—Epirubicin—ovarian cancer	5.81e-05	0.000533	CcSEcCtD
Letrozole—Dysgeusia—Epirubicin—ovarian cancer	5.8e-05	0.000532	CcSEcCtD
Letrozole—Diarrhoea—Paclitaxel—ovarian cancer	5.78e-05	0.00053	CcSEcCtD
Letrozole—Nervousness—Epirubicin—ovarian cancer	5.75e-05	0.000527	CcSEcCtD
Letrozole—Back pain—Epirubicin—ovarian cancer	5.73e-05	0.000525	CcSEcCtD
Letrozole—Angiopathy—Doxorubicin—ovarian cancer	5.71e-05	0.000523	CcSEcCtD
Letrozole—Mediastinal disorder—Doxorubicin—ovarian cancer	5.67e-05	0.00052	CcSEcCtD
Letrozole—Body temperature increased—Docetaxel—ovarian cancer	5.66e-05	0.000519	CcSEcCtD
Letrozole—Abdominal pain—Docetaxel—ovarian cancer	5.66e-05	0.000519	CcSEcCtD
Letrozole—Dizziness—Paclitaxel—ovarian cancer	5.59e-05	0.000512	CcSEcCtD
Letrozole—Vision blurred—Epirubicin—ovarian cancer	5.58e-05	0.000512	CcSEcCtD
Letrozole—Alopecia—Doxorubicin—ovarian cancer	5.56e-05	0.00051	CcSEcCtD
Letrozole—Mental disorder—Doxorubicin—ovarian cancer	5.51e-05	0.000505	CcSEcCtD
Letrozole—Ill-defined disorder—Epirubicin—ovarian cancer	5.49e-05	0.000504	CcSEcCtD
Letrozole—Malnutrition—Doxorubicin—ovarian cancer	5.48e-05	0.000502	CcSEcCtD
Letrozole—Tension—Doxorubicin—ovarian cancer	5.38e-05	0.000493	CcSEcCtD
Letrozole—Vomiting—Paclitaxel—ovarian cancer	5.37e-05	0.000493	CcSEcCtD
Letrozole—Dysgeusia—Doxorubicin—ovarian cancer	5.36e-05	0.000492	CcSEcCtD
Letrozole—Malaise—Epirubicin—ovarian cancer	5.34e-05	0.000489	CcSEcCtD
Letrozole—Rash—Paclitaxel—ovarian cancer	5.33e-05	0.000489	CcSEcCtD
Letrozole—Dermatitis—Paclitaxel—ovarian cancer	5.32e-05	0.000488	CcSEcCtD
Letrozole—Nervousness—Doxorubicin—ovarian cancer	5.32e-05	0.000488	CcSEcCtD
Letrozole—Vertigo—Epirubicin—ovarian cancer	5.32e-05	0.000488	CcSEcCtD
Letrozole—Leukopenia—Epirubicin—ovarian cancer	5.3e-05	0.000486	CcSEcCtD
Letrozole—Back pain—Doxorubicin—ovarian cancer	5.3e-05	0.000486	CcSEcCtD
Letrozole—Headache—Paclitaxel—ovarian cancer	5.29e-05	0.000485	CcSEcCtD
Letrozole—Palpitations—Epirubicin—ovarian cancer	5.23e-05	0.00048	CcSEcCtD
Letrozole—Cough—Epirubicin—ovarian cancer	5.17e-05	0.000474	CcSEcCtD
Letrozole—Vision blurred—Doxorubicin—ovarian cancer	5.16e-05	0.000473	CcSEcCtD
Letrozole—Asthenia—Docetaxel—ovarian cancer	5.14e-05	0.000471	CcSEcCtD
Letrozole—Hypertension—Epirubicin—ovarian cancer	5.11e-05	0.000469	CcSEcCtD
Letrozole—Ill-defined disorder—Doxorubicin—ovarian cancer	5.08e-05	0.000466	CcSEcCtD
Letrozole—Pruritus—Docetaxel—ovarian cancer	5.07e-05	0.000465	CcSEcCtD
Letrozole—Arthralgia—Epirubicin—ovarian cancer	5.04e-05	0.000462	CcSEcCtD
Letrozole—Chest pain—Epirubicin—ovarian cancer	5.04e-05	0.000462	CcSEcCtD
Letrozole—Myalgia—Epirubicin—ovarian cancer	5.04e-05	0.000462	CcSEcCtD
Letrozole—Anxiety—Epirubicin—ovarian cancer	5.02e-05	0.00046	CcSEcCtD
Letrozole—Nausea—Paclitaxel—ovarian cancer	5.02e-05	0.00046	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	5.01e-05	0.000459	CcSEcCtD
Letrozole—Discomfort—Epirubicin—ovarian cancer	4.98e-05	0.000457	CcSEcCtD
Letrozole—Malaise—Doxorubicin—ovarian cancer	4.94e-05	0.000453	CcSEcCtD
Letrozole—Dry mouth—Epirubicin—ovarian cancer	4.93e-05	0.000452	CcSEcCtD
Letrozole—Vertigo—Doxorubicin—ovarian cancer	4.92e-05	0.000451	CcSEcCtD
Letrozole—Leukopenia—Doxorubicin—ovarian cancer	4.9e-05	0.00045	CcSEcCtD
Letrozole—Diarrhoea—Docetaxel—ovarian cancer	4.9e-05	0.000449	CcSEcCtD
Letrozole—Palpitations—Doxorubicin—ovarian cancer	4.84e-05	0.000444	CcSEcCtD
Letrozole—Anaphylactic shock—Epirubicin—ovarian cancer	4.83e-05	0.000443	CcSEcCtD
Letrozole—Oedema—Epirubicin—ovarian cancer	4.83e-05	0.000443	CcSEcCtD
Letrozole—Infection—Epirubicin—ovarian cancer	4.8e-05	0.00044	CcSEcCtD
Letrozole—Cough—Doxorubicin—ovarian cancer	4.78e-05	0.000438	CcSEcCtD
Letrozole—Nervous system disorder—Epirubicin—ovarian cancer	4.74e-05	0.000434	CcSEcCtD
Letrozole—Dizziness—Docetaxel—ovarian cancer	4.74e-05	0.000434	CcSEcCtD
Letrozole—Hypertension—Doxorubicin—ovarian cancer	4.73e-05	0.000434	CcSEcCtD
Letrozole—Tachycardia—Epirubicin—ovarian cancer	4.72e-05	0.000432	CcSEcCtD
Letrozole—Skin disorder—Epirubicin—ovarian cancer	4.69e-05	0.00043	CcSEcCtD
Letrozole—Hyperhidrosis—Epirubicin—ovarian cancer	4.67e-05	0.000428	CcSEcCtD
Letrozole—Chest pain—Doxorubicin—ovarian cancer	4.66e-05	0.000428	CcSEcCtD
Letrozole—Myalgia—Doxorubicin—ovarian cancer	4.66e-05	0.000428	CcSEcCtD
Letrozole—Arthralgia—Doxorubicin—ovarian cancer	4.66e-05	0.000428	CcSEcCtD
Letrozole—Anxiety—Doxorubicin—ovarian cancer	4.65e-05	0.000426	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	4.63e-05	0.000425	CcSEcCtD
Letrozole—Discomfort—Doxorubicin—ovarian cancer	4.61e-05	0.000422	CcSEcCtD
Letrozole—Anorexia—Epirubicin—ovarian cancer	4.61e-05	0.000422	CcSEcCtD
Letrozole—Dry mouth—Doxorubicin—ovarian cancer	4.56e-05	0.000418	CcSEcCtD
Letrozole—Vomiting—Docetaxel—ovarian cancer	4.55e-05	0.000418	CcSEcCtD
Letrozole—Rash—Docetaxel—ovarian cancer	4.52e-05	0.000414	CcSEcCtD
Letrozole—Dermatitis—Docetaxel—ovarian cancer	4.51e-05	0.000414	CcSEcCtD
Letrozole—Headache—Docetaxel—ovarian cancer	4.49e-05	0.000411	CcSEcCtD
Letrozole—Anaphylactic shock—Doxorubicin—ovarian cancer	4.47e-05	0.00041	CcSEcCtD
Letrozole—Oedema—Doxorubicin—ovarian cancer	4.47e-05	0.00041	CcSEcCtD
Letrozole—Infection—Doxorubicin—ovarian cancer	4.44e-05	0.000407	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Epirubicin—ovarian cancer	4.4e-05	0.000404	CcSEcCtD
Letrozole—Nervous system disorder—Doxorubicin—ovarian cancer	4.38e-05	0.000402	CcSEcCtD
Letrozole—Insomnia—Epirubicin—ovarian cancer	4.37e-05	0.000401	CcSEcCtD
Letrozole—Tachycardia—Doxorubicin—ovarian cancer	4.36e-05	0.0004	CcSEcCtD
Letrozole—Skin disorder—Doxorubicin—ovarian cancer	4.34e-05	0.000398	CcSEcCtD
Letrozole—Paraesthesia—Epirubicin—ovarian cancer	4.34e-05	0.000398	CcSEcCtD
Letrozole—Hyperhidrosis—Doxorubicin—ovarian cancer	4.32e-05	0.000396	CcSEcCtD
Letrozole—Dyspnoea—Epirubicin—ovarian cancer	4.31e-05	0.000395	CcSEcCtD
Letrozole—Somnolence—Epirubicin—ovarian cancer	4.3e-05	0.000394	CcSEcCtD
Letrozole—Anorexia—Doxorubicin—ovarian cancer	4.26e-05	0.000391	CcSEcCtD
Letrozole—Nausea—Docetaxel—ovarian cancer	4.25e-05	0.00039	CcSEcCtD
Letrozole—Dyspepsia—Epirubicin—ovarian cancer	4.25e-05	0.00039	CcSEcCtD
Letrozole—Decreased appetite—Epirubicin—ovarian cancer	4.2e-05	0.000385	CcSEcCtD
Letrozole—Gastrointestinal disorder—Epirubicin—ovarian cancer	4.17e-05	0.000382	CcSEcCtD
Letrozole—Fatigue—Epirubicin—ovarian cancer	4.17e-05	0.000382	CcSEcCtD
Letrozole—Pain—Epirubicin—ovarian cancer	4.13e-05	0.000379	CcSEcCtD
Letrozole—Constipation—Epirubicin—ovarian cancer	4.13e-05	0.000379	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	4.07e-05	0.000373	CcSEcCtD
Letrozole—Insomnia—Doxorubicin—ovarian cancer	4.04e-05	0.000371	CcSEcCtD
Letrozole—Paraesthesia—Doxorubicin—ovarian cancer	4.01e-05	0.000368	CcSEcCtD
Letrozole—Dyspnoea—Doxorubicin—ovarian cancer	3.99e-05	0.000365	CcSEcCtD
Letrozole—Feeling abnormal—Epirubicin—ovarian cancer	3.98e-05	0.000365	CcSEcCtD
Letrozole—Somnolence—Doxorubicin—ovarian cancer	3.97e-05	0.000364	CcSEcCtD
Letrozole—Gastrointestinal pain—Epirubicin—ovarian cancer	3.95e-05	0.000362	CcSEcCtD
Letrozole—Dyspepsia—Doxorubicin—ovarian cancer	3.94e-05	0.000361	CcSEcCtD
Letrozole—Decreased appetite—Doxorubicin—ovarian cancer	3.89e-05	0.000356	CcSEcCtD
Letrozole—Gastrointestinal disorder—Doxorubicin—ovarian cancer	3.86e-05	0.000354	CcSEcCtD
Letrozole—Fatigue—Doxorubicin—ovarian cancer	3.85e-05	0.000353	CcSEcCtD
Letrozole—Urticaria—Epirubicin—ovarian cancer	3.84e-05	0.000352	CcSEcCtD
Letrozole—Constipation—Doxorubicin—ovarian cancer	3.82e-05	0.00035	CcSEcCtD
Letrozole—Pain—Doxorubicin—ovarian cancer	3.82e-05	0.00035	CcSEcCtD
Letrozole—Abdominal pain—Epirubicin—ovarian cancer	3.82e-05	0.00035	CcSEcCtD
Letrozole—Body temperature increased—Epirubicin—ovarian cancer	3.82e-05	0.00035	CcSEcCtD
Letrozole—Feeling abnormal—Doxorubicin—ovarian cancer	3.68e-05	0.000338	CcSEcCtD
Letrozole—Gastrointestinal pain—Doxorubicin—ovarian cancer	3.66e-05	0.000335	CcSEcCtD
Letrozole—Urticaria—Doxorubicin—ovarian cancer	3.55e-05	0.000326	CcSEcCtD
Letrozole—Body temperature increased—Doxorubicin—ovarian cancer	3.53e-05	0.000324	CcSEcCtD
Letrozole—Abdominal pain—Doxorubicin—ovarian cancer	3.53e-05	0.000324	CcSEcCtD
Letrozole—Asthenia—Epirubicin—ovarian cancer	3.47e-05	0.000318	CcSEcCtD
Letrozole—Pruritus—Epirubicin—ovarian cancer	3.42e-05	0.000313	CcSEcCtD
Letrozole—Diarrhoea—Epirubicin—ovarian cancer	3.31e-05	0.000303	CcSEcCtD
Letrozole—Asthenia—Doxorubicin—ovarian cancer	3.21e-05	0.000294	CcSEcCtD
Letrozole—Dizziness—Epirubicin—ovarian cancer	3.2e-05	0.000293	CcSEcCtD
Letrozole—Pruritus—Doxorubicin—ovarian cancer	3.16e-05	0.00029	CcSEcCtD
Letrozole—Vomiting—Epirubicin—ovarian cancer	3.07e-05	0.000282	CcSEcCtD
Letrozole—Diarrhoea—Doxorubicin—ovarian cancer	3.06e-05	0.00028	CcSEcCtD
Letrozole—Rash—Epirubicin—ovarian cancer	3.05e-05	0.000279	CcSEcCtD
Letrozole—Dermatitis—Epirubicin—ovarian cancer	3.04e-05	0.000279	CcSEcCtD
Letrozole—Headache—Epirubicin—ovarian cancer	3.03e-05	0.000278	CcSEcCtD
Letrozole—Dizziness—Doxorubicin—ovarian cancer	2.96e-05	0.000271	CcSEcCtD
Letrozole—Nausea—Epirubicin—ovarian cancer	2.87e-05	0.000263	CcSEcCtD
Letrozole—Vomiting—Doxorubicin—ovarian cancer	2.84e-05	0.000261	CcSEcCtD
Letrozole—Rash—Doxorubicin—ovarian cancer	2.82e-05	0.000258	CcSEcCtD
Letrozole—Dermatitis—Doxorubicin—ovarian cancer	2.82e-05	0.000258	CcSEcCtD
Letrozole—Headache—Doxorubicin—ovarian cancer	2.8e-05	0.000257	CcSEcCtD
Letrozole—Nausea—Doxorubicin—ovarian cancer	2.66e-05	0.000243	CcSEcCtD
